previous
demonstr
genet
engin
variant
footandmouth
diseas
viru
fmdv
serotyp
lack
leader
proteinasecod
region
attenu
induc
immun
respons
partial
protect
cattl
ffom
fmd
studi
test
swine
live
chemic
inactiv
vaccin
anim
vaccin
chemic
inactiv
wildtyp
wt
viru
oil
adjuv
develop
high
level
neutral
antibodi
protect
fmd
upon
challeng
anim
vaccin
live
exhibit
sign
fmd
spread
viru
anim
develop
neutral
antibodi
respons
antibodi
nonstructur
protein
partial
protect
fmd
anim
given
similar
dose
chemic
inactiv
absenc
adjuv
develop
poor
immun
respons
protect
fmd
indic
limit
replic
respons
improv
immun
respons
found
anim
vaccin
live
result
demonstr
potenti
liveattenu
vaccin
well
safe
sourc
antigen
chemic
inactiv
vaccin
elsevi
scienc
ltd
right
reserv
footandmouth
diseas
fmd
debilit
diseas
clovenhoof
anim
includ
swine
cattl
diseas
highli
contagi
character
fever
vesicular
lesion
mainli
feet
also
mouth
nose
sometim
teat
well
abort
neonat
death
infect
anim
rapidli
spread
viru
via
aerosol
other
result
dramat
loss
product
herd
fmd
outbreak
devast
countri
diseas
restrict
import
anim
anim
product
countri
diseas
present
fmd
found
infect
expos
anim
slaughter
ring
vaccin
surround
affect
area
may
implement
vaccin
prepar
chemic
inactiv
fmdv
use
success
control
howev
associ
diseas
outbreak
incomplet
chemic
inactiv
escap
usda
viru
vaccin
manufactur
furthermor
convent
vaccin
induc
rel
shortliv
immun
vaccin
anim
develop
carrier
state
follow
contact
last
yr
number
altern
approach
fmd
vaccin
develop
examin
one
approach
examin
liveattenu
vaccin
vaccin
base
stabli
attenu
fmdv
could
provid
improv
safeti
exist
product
moreov
work
viral
diseas
shown
liveattenu
vaccin
induc
longer
last
immun
present
greater
antigen
mass
result
limit
replic
inactiv
vaccin
deliv
natur
rout
induc
mucos
immun
fmdv
aphthoviru
famili
picomavirida
singlestrand
positivesens
rna
genom
surround
icosahedr
capsid
compos
four
structur
protein
vpl
rna
genom
contain
long
translat
open
read
frame
code
polyprotein
process
viral
encod
enzym
matur
structur
nonstructur
protein
fmdv
leader
l
protein
papainlik
proteinas
associ
viral
infect
cell
l
proteinas
autocatalyt
cleav
proteinasedefici
fmd
vaccin
j
chinsangaram
et
al
immunoprecipit
dpv
serum
swine
vaccin
lane
lane
beiinactiv
lane
control
swine
lane
immunoprecipit
bovin
convalesc
serum
lane
immunoprecipit
dpv
serum
swine
product
examin
sdspage
gel
viral
polyprotein
shut
capdepend
host
protein
synthesi
cleav
compon
capbind
complex
result
fmdv
initi
translat
capindepend
mechan
need
compet
host
mrna
use
cellular
translat
machineri
part
program
identifi
attenu
vaccin
candid
genet
alter
genom
fmdv
seroxp
delet
l
proteinas
code
region
contrast
attenu
virus
select
serial
passag
genet
unstabl
delet
l
protein
code
region
make
highli
unlik
leader
proteinasedefici
viru
revert
virul
previou
studi
shown
replic
slowli
parent
viru
babi
hamster
kidney
bhk
cellsn
attenu
aerosol
inocul
found
local
respiratori
bronchiol
produc
clinic
sign
cattl
contrast
caus
classic
fmd
includ
fever
vesicular
lesion
furthermor
demonstr
singl
subcutan
vaccin
live
induc
partial
protect
immun
respons
cattl
sever
challeng
intraderm
inocul
tongu
virul
cattlepassag
fmdv
shown
cattl
swine
necessarili
re
ond
fmd
vaccin
infect
similar
fashior
e
differ
diseas
suscept
cattl
swine
also
suggest
recent
fmd
outbreak
taiwan
swine
popul
devast
signific
diseas
cattl
present
studi
safeti
efficaci
live
inactiv
vaccin
prepar
test
swine
proteinasedefici
fmd
vaccin
j
chinsangaram
et
al
babi
hamster
kidney
bhk
cell
strain
clone
use
propag
viru
stock
plaqu
reduct
neutral
prn
assay
secondari
lamb
kidney
lk
cell
provid
dr
c
hous
foreign
anim
diseas
diagnost
laboratori
usda
plum
island
usa
use
produc
antigen
radioimmunoprecipit
rip
parent
wildtyp
wt
fmdv
virul
cattlepassa
ed
g
strain
fmdv
describ
previous
virus
purifi
sucrosegradi
centrifug
chemic
inactiv
treatment
binari
ethylenimin
bei
previous
describ
sixteen
kg
yorkshir
cross
yorkshir
bluepoint
gilt
divid
four
vaccin
group
three
anim
two
group
two
control
anim
anim
hous
two
separ
room
first
room
contain
one
group
anim
vaccin
subcutan
pg
live
pfu
two
control
anim
second
room
contain
three
group
anim
remain
two
control
anim
group
anim
second
room
vaccin
either
subcutan
day
postvaccin
pug
beiinactiv
intramuscularli
pg
beiinactiv
miner
oil
l
pg
beiinactiv
adjuv
day
postvaccin
dpv
anim
combin
singl
room
challeng
live
fmdv
inocul
singl
control
anim
intraderm
snout
combin
intraderm
coronari
band
heel
bulb
skin
scarif
coronari
band
one
foot
total
x
infecti
unit
virul
cattlepassag
fmdv
type
rectal
temperatur
data
clinic
sign
includ
lame
vesicular
lesion
record
daili
temperatur
two
consecut
day
consid
constitut
fever
time
necropsi
number
digit
affect
diseas
record
score
anim
see
tabl
serum
sampl
collect
everi
week
use
prn
rip
assay
rip
perform
use
cytoplasm
extract
methioninelabel
fmdvinfect
lk
cell
serum
sampl
screen
antibodi
fmdv
structur
nonstructur
protein
dilut
rip
precipit
product
analyz
sdspage
gel
serum
sampl
serial
dilut
assay
neutral
antibodi
prn
bhk
cell
neutral
titer
report
log
serum
dilut
yield
reduct
pfu
prn
intramuscular
vaccin
beiinactiv
viru
adjuv
induc
high
neutral
antibodi
titer
tabl
anim
antibodi
viral
structur
protein
detect
rip
figur
neutral
antibodi
first
detect
anim
dpv
plateau
dpv
figur
subcutan
vaccin
beiinactiv
viru
absenc
adjuv
induc
lower
neutral
antibodi
respons
tabl
titer
appear
declin
slightli
time
figur
latter
group
anim
develop
antibodi
viral
structur
protein
could
detect
rip
lane
figur
expect
anim
figur
immunoprecipit
viral
protein
serum
swine
vaccin
live
beiinactiv
absenc
adjuv
cytoplasm
extract
fmdvinfect
lk
cell
radiolabel
jmethionin
immunoprecipit
dpv
serum
swine
vaccin
lane
live
lane
beiinactiv
al
absenc
adjuv
lane
control
swine
lane
immunoprecipit
bovin
convalesc
serum
lane
immunoprecipit
dpv
serum
swine
product
examin
sdspage
gel
given
inactiv
virus
produc
detect
antibodi
nonstructur
protein
includ
figur
tabl
contrast
anim
given
inactiv
viru
prepar
anim
vaccin
live
develop
antibodi
nonstructur
protein
structur
protein
dpv
lane
figur
presenc
antibodi
viral
nonstructur
protein
indic
viru
replic
anim
howev
anim
show
clinic
sign
fmd
includ
lame
fever
appar
lesion
feet
mouth
addit
two
control
anim
hous
room
swine
day
seroconvert
show
sign
fmd
indic
spread
viru
anim
tabl
lane
figur
follow
commingl
anim
singl
room
one
control
anim
infect
virul
cattlepassag
viru
snout
one
foot
vesicular
lesion
observ
foot
snout
day
postchalleng
dpc
respect
vesicl
develop
follow
day
four
feet
anim
temperatur
persist
two
four
seven
dpc
figur
c
remain
control
anim
vesicular
lesion
dpc
one
anim
also
develop
vesicl
snout
anim
vaccin
subcutan
beiinactiv
absenc
adjuv
protect
challeng
tabl
l
although
three
anim
delay
appear
vesicl
dpc
compar
control
swine
anim
vaccin
subcutan
live
partial
protect
challeng
tabl
anim
develop
fever
figur
delay
appear
vesicl
dpc
one
anim
group
develop
vesicl
four
feet
although
low
score
see
tabl
fever
figur
tabl
found
anim
vaccin
beiinactiv
adjuv
period
observ
day
sera
collect
dpc
evalu
determin
extent
challeng
viru
replic
expos
anim
result
reveal
strong
boost
neutral
antibodi
titer
anim
vaccin
subcutan
either
live
beiinactiv
increas
neutral
titer
anim
vaccin
intramuscularli
beiinactiv
figur
tabl
moreov
rip
analys
reveal
latter
two
group
anim
fail
develop
antibodi
nonstructur
protein
follow
exposur
indic
replic
challeng
viru
absent
limit
anim
figur
studi
shown
leader
proteinasedefici
deriv
fmdv
serotyp
safe
administ
swine
vaccin
swine
produc
neutral
antibodi
partial
protect
virul
viru
challeng
replic
live
swine
confirm
detect
antibodi
nonstructur
protein
presum
improv
immun
respons
rel
observ
anim
vaccin
inactiv
rout
subcutan
vaccin
absenc
adjuv
spite
evid
viru
replic
vaccin
live
produc
sign
diseas
spread
control
anim
result
togeth
previou
result
cattl
see
section
demonstr
safeti
liveattenu
vaccin
candid
livestock
howev
extens
studi
involv
anim
variou
age
immun
statu
requir
unequivoc
address
safeti
type
vaccin
candid
sever
diseas
judg
lesion
score
rectal
temperatur
correl
well
neutral
antibodi
titer
measur
day
challeng
tabl
anim
vaccin
beiinactiv
oil
adjuv
develop
high
titer
neutral
antibodi
protect
challeng
thu
expect
delet
l
proteinas
code
region
alter
antigen
structur
virion
anim
vaccin
volum
number
nate
live
lower
level
neutral
antibodi
compar
anim
vaccin
beitreat
viru
presenc
adjuv
partial
protect
virul
viru
challeng
determin
absenc
fever
delay
lesion
appear
low
lesion
score
anim
vaccin
beiinactiv
absenc
adjuv
display
low
nondetect
neutral
antibodi
titer
day
challeng
although
lesion
appear
later
anim
control
anim
end
challeng
period
differ
diseas
sever
notic
two
group
subcutan
vaccin
live
chosen
studi
allow
comparison
previou
studi
cattl
addit
rout
inocul
select
base
studi
cattl
indic
subcutan
better
intramuscular
vaccin
term
abil
induc
neutral
antibodi
unpublish
observ
subcutan
inocul
cattl
induc
neutral
antibodi
titer
prn
anim
highest
titer
protect
challeng
anim
prnto
develop
fever
pedal
lesion
third
anim
prn
develop
fever
mild
lesion
present
studi
show
vaccin
swine
rout
induc
similar
neutral
antibodi
titer
swine
partial
protect
challeng
anim
develop
fever
display
low
lesion
score
sinc
immun
respons
live
given
dpc
serum
swine
respect
lane
immunoprecipit
bovin
convalesc
serum
lane
immunoprecipit
cl
dpv
serum
swine
product
examin
sdspage
gel
subcutan
rout
superior
seen
anim
given
antigen
mass
inactiv
rout
studi
demonstr
replic
live
viru
anim
respons
part
increas
immun
respons
problem
associ
convent
fmd
vaccin
led
us
search
safer
vaccin
candid
develop
attenu
fmd
vaccin
passag
unnatur
host
obtain
virus
innocu
yet
abl
induc
protect
immun
respons
proven
addit
virus
select
procedur
revert
virul
taken
approach
delet
entir
l
code
region
fmdv
produc
attenu
viru
suitabl
use
live
vaccin
viru
delet
complet
code
region
significantli
reduc
risk
revers
virul
compar
attenu
virus
produc
convent
mean
moreov
demonstr
viru
use
sourc
antigen
tradit
beiinactiv
vaccin
sinc
nonpathogen
spread
anim
use
vaccin
product
could
reduc
risk
associ
current
vaccin
manufactur
result
studi
conjunct
previou
result
suggest
vaccin
cattl
swine
live
feasibl
howev
limit
replic
attenu
viru
result
increas
antigen
mass
insuffici
induc
complet
protect
immun
respons
addit
studi
current
ongo
demonstr
sifeti
improv
efficaci
complet
understand
host
respons
attenu
viru
infect
